# US 2025/0155355 A1 · Method and device for high throughput cell deformability measurements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0155355 A1
- Document ID: US20250155355A1
- Status: Published application
- Kind: A1
- Application number: 19/025,994
- Filed: 2025-01-16
- Published: 2025-05-15
- Earliest claimed: 2010-09-22
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Dino Di Carlo; Daniel R. Gossett; Henry T.K. Tse
- Web page: https://patentgrep.com/patent/US20250155355A1

## CPC

- G01N 15/1433: using image recognition
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- B01L 3/502776: {specially adapted for focusing or laminating flows}
- C12Q 1/02: involving viable microorganisms
- G01N 15/1404: Handling flow, e.g. hydrodynamic focusing
- G01N 15/1459: {the analysis being performed on a sample stream}
- G01N 15/1484: {microstructural devices}
- G01N 33/487: of liquid biological material
- G01N 33/575: for cancer
- G16B 99/00: Subject matter not provided for in other groups of this subclass
- B01L 2200/0605: Metering of fluids
- B01L 2200/0647: Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L 2200/0652: Sorting or classification of particles or molecules
- B01L 2200/0663: Stretching or orienting elongated molecules or particles
- B01L 2300/0654: Lenses; Optical fibres
- B01L 2300/0681: Filter
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0864: comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
- G01N 15/01: specially adapted for biological cells, e.g. blood cells (investigating sedimentation of particle suspensions in blood G01N15/05)
- G01N 15/149: specially adapted for sorting particles, e.g. by their size or optical properties
- G01N 2015/1006: {for cytology}
- G01N 2015/1415: {Control of particle position}
- G01N 2015/1495: {Deformation of particles}
- G01N 2015/1497: {Particle shape}
- G01N 2800/7028: Cancer
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

A system is disclosed that enables the automated measurement of cellular mechanical parameters at high throughputs. The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching. Cells are focused into streamlines prior to entering the extensional flow region. In the extensional region, each cell's deformation is measured with an imaging device. Automated image analysis extracts a range of independent biomechanical parameters from the images. These may include cell size, deformability, and circularity. The single cell data that is obtained may then be used to in a variety of ways. Scatter density plots of deformability and circularity may be developed and displayed for the user. Mechanical parameters such as deformability and circularity may be gated or thresholded to identify certain cells of interest or sub-populations of interest. Similarly, the mechanical data obtained using the device may be used as cell signatures.

## Claims

### Claim 1

A method for testing a cell sample for a disease state, the method comprising:
receiving the cell sample from an individual;
measuring values of a set of characteristics of the cell sample by performing operations comprising:
passing a plurality of cells from the cell sample through a region of a microfluidic channel, and
determining a value of a morphological parameter of a cell of the plurality of cells as the cell passes through the region of the microfluidic channel,
wherein the set of characteristics comprises the morphological parameter of the cell; and
displaying a representation of a suspicion of the disease state based on the values of the set of characteristics, wherein the representation comprises an illustration of the disease state separately from non-disease state.

### Claim 2 (depends on 1)

The method of claim 1, wherein the cell sample comprises a leukocyte.

### Claim 3 (depends on 1)

The method of claim 1, wherein the plurality of cells passes through the region of the microfluidic channel at a rate of at least about 1000 cells/second.

### Claim 4 (depends on 1)

The method of claim 1, wherein the plurality of cells passes through the microfluidic channel at a velocity of at least about 1 m/s.

### Claim 5 (depends on 1)

The method of claim 1, wherein the cell passes through the region in less than about 500 μs.

### Claim 6 (depends on 1)

The method of claim 1, wherein the morphological parameter comprises a cell shape, cell circularity, or cell size.

### Claim 7 (depends on 6)

The method of claim 6, wherein the morphological parameter comprises the cell size.

### Claim 8 (depends on 1)

The method of claim 1, wherein the measuring the values of the set of the characteristics further comprises applying a threshold to the value of the morphological parameter of the cell.

### Claim 9 (depends on 8)

The method of claim 8, wherein the threshold is applied to determine if a cell indicates a positive or negative disease state.

### Claim 10 (depends on 9)

The method of claim 9, wherein the suspicion of the disease state is based on a percentage of cells of the plurality of cells that are identified as indicating the positive disease state.

### Claim 11 (depends on 10)

The method of claim 10, wherein the positive disease state is based at least in part on a size of the cell.

### Claim 12 (depends on 1)

The method of claim 1, wherein the displaying a representation of a suspicion of the disease state comprises a plot of the values of the set of characteristics of the cell sample.

### Claim 13 (depends on 12)

The method of claim 12, wherein the plot is a scatter plot.

### Claim 14 (depends on 13)

The method of claim 13, wherein an axis of the scatter plot comprises the morphological parameter.

### Claim 15 (depends on 1)

The method of claim 1, further comprising diagnosing the individual based at least on a distribution of the values of the set of characteristics of the cell sample.

### Claim 16 (depends on 1)

The method of claim 1, wherein the suspicion of the disease state is based at least in part on an activation of a leukocyte.
